On ECHEMI
Home > Drugs > Restrictive cardiomyopathy in children
Restrictive cardiomyopathy in children
Restrictive cardiomyopathy (RCM), also known as occlusive cardiomyopathy, is relatively rare. Due to endocardial and/or myocardial lesions, ventricular distensibility is reduced, diastolic filling is impaired, and heart failure occurs. Restrictive cardiomyopathy is a cardiomyopathy characterized by fibrosis and hyperplasia of the endocardium and subendocardial myocardium, mural thrombosis, cardiac chamber shrinkage or occlusion, ventricular filling disorder and decreased compliance, severe damage to cardiac diastolic function, and normal or mildly impaired systolic function.
  • Site of disease:

    heart
  • Infectious :

    Not contagious
  • Frequent population:

    Infants and young children
  • Related symptoms:

    Systolic murmur Pulsus paradoxus Dyspnea Distended jugular veins Hepatomegaly
  • Concurrent disease:

Related Drugs
Pefloxacin mesylate
Indication: No data yet
Manufacturer:

INNER MONGOLIA Tongliao Pharmaceutical Co., Ltd.

Pefloxacin mesylate
Indication: No data yet
Manufacturer:

Shanxi Yuhua Fine Chemical Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.